The Blurring Lines: How Imaging and Clinical Labs Have a Role in Diagnosing AIH
Diagnosing AIH often requires an invasive biopsy. But a new class of imaging allows for non-invasive diagnosis of new and recurring AIH.
Read MorePosted by Chris Wolski | Jun 30, 2022 | Allergy & Autoimmune |
Diagnosing AIH often requires an invasive biopsy. But a new class of imaging allows for non-invasive diagnosis of new and recurring AIH.
Read MorePosted by Andy Lundin | Jun 27, 2022 | Cancer, Diagnostic Technologies |
Proteomics technology company SomaLogic signed a licensing agreement with OncoHost to develop new cancer diagnostics solutions.
Read MorePosted by Andy Lundin | Jun 23, 2022 | Unknown Origin & Other Cancer Types |
Researchers developed a blood test to predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Diabetes & Metabolic Diseases |
A specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MorePosted by Andy Lundin | Jun 22, 2022 | Company News, Diagnostic Technologies |
LightDeck Diagnostics has been awarded a grant to build a rapid, portable, quantitative test to detect many PFAS simultaneously.
Read More